au.\*:("FRANK MM")
Results 1 to 25 of 90
Selection :
COMPLEMENT RECEPTORS AND HISTAMINE DEGRADATIONFRANK MM.1980; J. ALLERGY CLIN. IMMUNOL.; ISSN 0091-6749; USA; DA. 1980; VOL. 66; NO 4; PP. 267-268; BIBL. 8 REF.Article
COMPLEMENT-INDEPENDENT CLEARANCE OF IGG SENSITIZED ERYTHROCYTES: INHIBITION BY CORTISONE = ELIMINATION INDEPENDANTE DU COMPLEMENT DES HEMATIES SENSIBILISEES PAR LES IGG: INHIBITION PAR LA CORTISONEATKINSON JP; FRANK MM.1974; BLOOD; U.S.A.; DA. 1974; VOL. 44; NO 5; PP. 629-637; BIBL. 27 REF.Article
STUDIES OF COMPLEMENT-MEDIATED MEMBRANE DAMAGE: THE INFLUENCE OF ERYTHROCYTE STORAGE ON SUSCEPTIBILITY TO CYTOLYSIS = ETUDE DE LA LESION DE LA MEMBRANE MEDIEE PAR LE COMPLEMENT: L'INFLUENCE DE LA CONSERVATION DES ERYTHROCYTES SUR LA SENSIBILITE A LA CYTOLYSEGAITHER TA; FRANK MM.1973; J. IMMUNOL.; U.S.A.; DA. 1973; VOL. 110; NO 2; PP. 482-489; BIBL. 19REF.Serial Issue
ROLE OF ANTIBODY AND COMPLEMENT IN THE IMMUNE CLEARANCE AND DESTRUCTION OF ERYTHROCYTES. I. IN VIVO EFFECTS OF IGG AND IGM COMPLEMENT-FIXING SITES = ROLE DES ANTICORPS ET DU COMPLEMENT DANS L'EPURATION IMMUNITAIRE ET LA DESTRUCTION DES ERYTHROCYTES. I. EFFETS IN VIVO DES SITES DE FIXATION DU COMPLEMENT SUR IGG ET IGMSCHREIBER AD; FRANK MM.1972; J. CLIN. INVEST.; U.S.A.; DA. 1972; VOL. 51; NO 3; PP. 575-582; BIBL. 30 REF.Serial Issue
ROLE OF ANTIBODY AND COMPLEMENT IN THE IMMUNE CLEARANCE AND DESTRUCTION OF ERYTHROCYTES. II. MOLECULAR NATURE OF IGG AND IGM COMPLEMENTFIXING SITES AND EFFECTS OF THEIR INTERACTION WITH SERUM = ROLE DE L'ANTICORPS ET DU COMPLEMENT DANS L'EPURATION ET LA DESTRUCTION IMMUNITAIRE DES ERYTHROCYTES. II. NATURE MOLECULAIRE DES SITES DE FIXATION DU COMPLEMENT DES IGG ET DES IGM ET RESULTAT DE LEUR INTERACTION AVEC LE SERUMSCHREIBER AD; FRANK MM.1972; J. CLIN. INVEST.; U.S.A.; DA. 1972; VOL. 51; NO 3; PP. 583-589; BIBL. 24 REF.Serial Issue
THE COMPLEMENT SYSTEM IN CLINICAL DIAGNOSISLAWLEY TJ; FRANK MM.1979; INTERNATION. J. DERMATOL.; USA; DA. 1979; VOL. 18; NO 9; PP. 673-680; BIBL. 13 REF.Article
FAILURE OF CYTOTOXIC AGENTS TO INHIBIT THE CLEARANCE OF SENSITIZED ERYTHROCYTES = INCAPACITE D'AGENTS CYTOTOXIQUES A INHIBER L'ELIMINATION D'ERYTHROCYTES SENSIBILISESATKINSON JP; FRANK MM.1974; J. RETICULOENDOTHEL. SOC.; U.S.A.; DA. 1974; VOL. 16; NO 2; PP. 122-130; BIBL. 1P.Article
STUDIES ON THE IN VIVO EFFECTS OF ANTIBODY. INTERACTION OF IGM ANTIBODY AND COMPLEMENT IN THE IMMUNE CLEARANCE AND DESTRUCTION OF ERYTHROCYTES IN MAN = ETUDES SUR LES ACTIONS IN VIVO DE L'ANTICORPS. INTERACTION DE L'ANTICORPS IGM ET DU COMPLEMENT DANS LA DESTRUCTION ET LA CLEARANCE IMMUNE DES ERYTHROCYTES CHEZ L'HOMMEATKINSON JP; FRANK MM.1974; J. CLIN. INVEST.; U.S.A.; DA. 1974; VOL. 54; NO 2; PP. 339-348; BIBL. 1P.1/2Article
ROLE OF COMPLEMENT IN THE PATHOPHYSIOLOGY OF HEMATOLOGIC DISEASES.ATKINSON JP; FRANK MM.1977; PROGR. IN HEMATOL.; U.S.A.; DA. 1977; VOL. 10; PP. 211-245; BIBL. 6 P. 1/2Article
THE EFFECT OF BACILLUS CALMETTE-GUERIN-INDUCED MACROPHAGE ACTIVATION ON THE IN VIVO CLEARANCE OF SENSITIZED ERYTHROCYTESATKINSON JP; FRANK MM.1974; J. CLIN. INVEST.; U.S.A.; DA. 1974; VOL. 53; NO 6; PP. 1743-1749; BIBL. 1P.Article
STUDIES OF THE MOLECULAR MECHANISMS OF C3B INACTIVATION AND A SIMPLIFIED ASSAY OF BETA 1H AND THE C3B INACTIVATOR (C3BINA)GAITHER TA; HAMMER CH; FRANK MM et al.1979; J. IMMUNOL.; USA; DA. 1979; VOL. 123; NO 3; PP. 1195-1204; BIBL. 35 REF.Article
DEPOSITION OF COMPLEMENT COMPONENTS IN THE CUTANEOUS LESIONS OF CHRONIC MUCOCUTANEOUS CANDIDIASISSOHNLE PG; FRANK MM; KIRKPATRICK CH et al.1976; CLIN. IMMUNOL. IMMUNOPATHOL.; U.S.A.; DA. 1976; VOL. 5; NO 3; PP. 340-350; BIBL. 19 REF.Article
LINKAGE OF THE GENE CONTROLLING THE SYNTHESIS OF THE FOURTH COMPONENT TO THE MAJOR HISTOCOMPATIBILITY COMPLEX OF THE GUINEA PIG.SHEVACH EM; FRANK MM; GREEN I et al.1976; IMMUNOGENETICS; GERM.; DA. 1976; VOL. 3; NO 6; PP. 595-601; BIBL. 1 P.Article
THE ROLE OF COMPLEMENT IN THE LOCALIZATION OF PNEUMOCOCCI IN THE SPLANCHNIC RETICULOENDOTHELIAL SYSTEM DURING EXPERIMENTAL BACTEREMIABROWN EJ; HOSEA SW; FRANK MM et al.1981; J. IMMUNOL.; ISSN 0022-1767; USA; DA. 1981; VOL. 126; NO 6; PP. 2230-2235; BIBL. 41 REF.Article
COLD AGGLUTININS AND COLD-AGGLUTININ DISEASE.FRANK MM; ATKINSON JP; GADEK J et al.1977; ANNU. REV. MED.; U.S.A.; DA. 1977; VOL. 28; PP. 291-298; BIBL. 2 P.Article
KINETIC ANALYSIS OF CHEMOTACTIC FACTOR GENERATION IN HUMAN SERUM VIA ACTIVATION OF THE CLASSICAL AND ALTERNATE COMPLEMENT PATHWAYSGALLIN JI; CLARK RA; FRANK MM et al.1975; CLIN. IMMUNOL. IMMUNOPATHOL.; U.S.A.; DA. 1975; VOL. 3; NO 3; PP. 334-346; BIBL. 23REF.Article
A NEW ONE-STEP METHOD FOR THE FUNCTIONAL ASSAY OF THE FOURTH COMPONENT (C4) OF HUMAN AND GUINEA PIG COMPLEMENTGAITHER TA; ALLING DW; FRANK MM et al.1974; J. IMMUNOL.; U.S.A.; DA. 1974; VOL. 113; NO 2; PP. 574-583; BIBL. 11REF.Article
GENERATION OF CHEMOTACTIC FACTORS IN GUINEA PIG SERUM VIA ACTIVATION OF THE CLASSICAL AND ALTERNATE COMPLEMENT PATHWAYSCLARK RA; FRANK MM; KIMBALL HR et al.1973; CLIN. IMMUNOL. IMMUNOPATHOL.; U.S.A.; DA. 1973; VOL. 1; NO 3; PP. 414-426; BIBL. 22REF.Serial Issue
HOST DEFENSE AGAINST BACTERIAL ENDOTOXEMIA-CONTRIBUTION OF THE EARLY AND LATE COMPONENTS OF COMPLEMENT TO DETOXIFICATIONMAY JE; KANE MA; FRANK MM et al.1972; J. IMMUNOL.; U.S.A.; DA. 1972; VOL. 109; NO 4; PP. 893-895; BIBL. 11 REF.Serial Issue
IMMUNE ADHERENCE BY THE ALTERNATE COMPLEMENT PATHWAY = IMMUNE ADHERENCE PAR L'AUTRE VOIE DU COMPLEMENTMAY JE; KANE MA; FRANK MM et al.1972; PROC. SOC. EXPER. BIOL. MED.; U.S.A.; DA. 1972; VOL. 141; NO 1; PP. 287-290; BIBL. 16REF.Serial Issue
THE ALTERNATE COMPLEMENT PATHWAY IN CELL DAMAGE: ANTIBODY-MEDIATED CYTOLYSIS OF ERYTHROCYTES AND NUCLEATED CELLS = LA VOIE ALTERNEE DU COMPLEMENT DANS LA LYSE CELLULAIRE: CYTOLYSE D'HEMATITES ET DE CELLULES NUCLEEES PAR L'INTERMEDIAIRE DE L'ANTICORPSMAY JE; GREEN I; FRANK MM et al.1972; J. IMMUNOL.; U.S.A.; DA. 1972; VOL. 109; NO 3; PP. 595-601; BIBL. 22REF.Serial Issue
MECHANISMS INVOLVED IN ELIMINATION OF ORGANISMS FROM EXPERIMENTAL CUTANEOUS CANDIDA ALBICANS INFECTIONS IN GUINEA PIGS.SOHNLE PG; FRANK MM; KIRKPATRICK CH et al.1976; J. IMMUNOL.; U.S.A.; DA. 1976; VOL. 117; NO 2; PP. 523-530; BIBL. 21 REF.Article
A RECEPTOR FOR THE THIRD COMPONENT OF COMPLEMENT IN THE HUMAN RENAL GLOMERULUS.GELFAND MC; FRANK MM; GREEN I et al.1975; J. EXPER. MED.; U.S.A.; DA. 1975; VOL. 142; NO 4; PP. 1029-1034; BIBL. 10 REF.Article
RETICULOENDOTHELIAL CLEARANCE OF RADIOLABELLED PNEUMOCOCCI IN EXPERIMENTAL BACTEREMIA: CORRELATION OF CHANGES IN CLEARANCE RATES, SEQUESTRATION PATTERNS AND OPSONIZATION REQUIREMENTS AT DIFFERENT PHASES OF THE BACTERIAL GROWTH CYCLEBROWN EJ; HOSEA SW; FRANK MM et al.1981; J. RETICULOENDOTHEL. SOC.; ISSN 0033-6890; USA; DA. 1981; VOL. 30; NO 1; PP. 23-31; BIBL. 22 REF.Article
HEREDITARY ANGIOEDEMA: THE CLINICAL SYNDROME AND ITS MANAGEMENTFRANK MM; GELFAND JA; ATKINSON JP et al.1976; ANN. INTERN. MED.; U.S.A.; DA. 1976; VOL. 84; NO 5; PP. 580-593; BIBL. 1 P. 1/2Article